AI entity

KEYTRUDA

Company

All 1 tracked stories fall under one category: partnership. KEYTRUDA is most often covered alongside Argus Research, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. KEYTRUDA appears in 1 tracked AI story from August 22, 2026.

Last mentioned: 1d ago

Entity pulse

Recent coverage · KEYTRUDA

1 story
6 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about KEYTRUDA

All 1 tracked stories fall under one category: partnership. KEYTRUDA is most often covered alongside Argus Research, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. KEYTRUDA appears in 1 tracked AI story from August 22, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 9 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering KEYTRUDA. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Argus raises Merck price target

    Argus lifts its Merck target from $130 to $145 with a Buy rating, citing pipeline depth and clinical progress.

  2. Merck discloses Evaxion stake

    Merck reports holding 1,214,126 shares of Evaxion A/S in a regulatory filing.

  3. Merck exercises EVX-B3 option

    Merck decides to in-license Evaxion's discovery-stage AI-derived vaccine candidate EVX-B3 against an undisclosed bacterial pathogen.

Stories mentioning KEYTRUDA 1

KEYTRUDA is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.